tmprss6 rnai sln124
Generic: TMPRSS6 RNAi SLN124
tmprss6 rnai sln124: 1 clinical trial tracked.
tmprss6 rnai sln124 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about tmprss6 rnai sln124, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
Phase 1/2 Study With an Open-label Dose Escalation Phase Followed by a Randomized, Double-blind Phase of SLN124 in Patients With Polycythemia Vera
Primary endpoint: Phase 1: Incidence of treatment-emergent adverse events (AEs)
InterventionalRandomizeddouble69 enrolledStarted 2023-01Completion 2030-0328 sites · Australia, Bulgaria, Canada, Germany…Silence Therapeutics plc